Combination of apatinib and docetaxel in treating advanced non-squamous non-small cell lung cancer patients with...
Original Article
Combination of apatinib and docetaxel in treating advanced non-squamous non-small cell lung cancer patients with wild-type EGFR: a multi-center, phase II trial